These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26964498)

  • 21. Vesicular phospholipid gels as drug delivery systems for small molecular weight drugs, peptides and proteins: State of the art review.
    Breitsamer M; Winter G
    Int J Pharm; 2019 Feb; 557():1-8. PubMed ID: 30572079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proprietary Rel-Ease drug delivery technology: opportunity for sustained delivery of peptides, proteins and small molecules.
    Ye M; Bhat G; Johnston KA; Tan H; Garnick M
    Expert Opin Drug Deliv; 2006 Sep; 3(5):663-75. PubMed ID: 16948561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanoparticles Conjugated with Photocleavable Linkers for the Intracellular Delivery of Biomolecules.
    Jiménez-Balsa A; Pinto S; Quartin E; Lino MM; Francisco V; Ferreira L
    Bioconjug Chem; 2018 May; 29(5):1485-1489. PubMed ID: 29652487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Research progress of ocular sustained-release corticosteroid delivery systems].
    Liu ZY; Chen YY
    Zhonghua Yan Ke Za Zhi; 2018 Feb; 54(2):154-160. PubMed ID: 29429302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current advances in sustained-release systems for parenteral drug delivery.
    Shi Y; Li LC
    Expert Opin Drug Deliv; 2005 Nov; 2(6):1039-58. PubMed ID: 16296808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biodegradable implants for sustained drug release in the eye.
    Lee SS; Hughes P; Ross AD; Robinson MR
    Pharm Res; 2010 Oct; 27(10):2043-53. PubMed ID: 20535532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multi-Layered Nanomicelles as Self-Assembled Nanocarrier Systems for Ocular Peptide Delivery.
    Mandal A; Patel P; Pal D; Mitra AK
    AAPS PharmSciTech; 2019 Jan; 20(2):66. PubMed ID: 30627825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PLGA micro and nanoparticles in delivery of peptides and proteins; problems and approaches.
    Mohammadi-Samani S; Taghipour B
    Pharm Dev Technol; 2015 Jun; 20(4):385-93. PubMed ID: 24483777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chitosan and its role in ocular therapeutics.
    Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
    Mini Rev Med Chem; 2009 Dec; 9(14):1639-47. PubMed ID: 20105127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An injectable thermosensitive polymeric hydrogel for sustained release of Avastin® to treat posterior segment disease.
    Xie B; Jin L; Luo Z; Yu J; Shi S; Zhang Z; Shen M; Chen H; Li X; Song Z
    Int J Pharm; 2015 Jul; 490(1-2):375-83. PubMed ID: 26027491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production methods and stabilization strategies for polymer-based nanoparticles and microparticles for parenteral delivery of peptides and proteins.
    Teekamp N; Duque LF; Frijlink HW; Hinrichs WL; Olinga P
    Expert Opin Drug Deliv; 2015 Aug; 12(8):1311-31. PubMed ID: 25601515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extended ocular drug delivery systems for the anterior and posterior segments: biomaterial options and applications.
    Kang-Mieler JJ; Dosmar E; Liu W; Mieler WF
    Expert Opin Drug Deliv; 2017 May; 14(5):611-620. PubMed ID: 27551742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biodegradable thermosensitive polymer gel for sustained BMP-2 delivery.
    Park K
    J Control Release; 2015 Jul; 209():337. PubMed ID: 26048771
    [No Abstract]   [Full Text] [Related]  

  • 34. Biodegradable Microspheres as Intravitreal Delivery Systems for Prolonged Drug Release. What is their Eminence in the Nanoparticle Era?
    Gavini E; Bonferoni MC; Rassu G; Obinu A; Ferrari F; Giunchedi P
    Curr Drug Deliv; 2018; 15(7):930-940. PubMed ID: 29484995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term delivery of protein and peptide therapeutics for cancer therapies.
    Sikder S; Gote V; Alshamrani M; Sicotte J; Pal D
    Expert Opin Drug Deliv; 2019 Oct; 16(10):1113-1131. PubMed ID: 31498012
    [No Abstract]   [Full Text] [Related]  

  • 36. Nanoparticles of poly(lactide)-tocopheryl polyethylene glycol succinate (PLA-TPGS) copolymers for protein drug delivery.
    Lee SH; Zhang Z; Feng SS
    Biomaterials; 2007 Apr; 28(11):2041-50. PubMed ID: 17250886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of ocular drug delivery systems using molecularly imprinted soft contact lenses.
    Tashakori-Sabzevar F; Mohajeri SA
    Drug Dev Ind Pharm; 2015 May; 41(5):703-13. PubMed ID: 25113431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanoparticle-based topical ophthalmic formulations for sustained celecoxib release.
    Ibrahim MM; Abd-Elgawad AE; Soliman OA; Jablonski MM
    J Pharm Sci; 2013 Mar; 102(3):1036-53. PubMed ID: 23293035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biodegradable and biocompatible thermosensitive polymer based injectable implant for controlled release of protein.
    Tang Y; Singh J
    Int J Pharm; 2009 Jan; 365(1-2):34-43. PubMed ID: 18786623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sustained protein release from hydrogel microparticles using layer-by-layer (LbL) technology.
    Sakr OS; Jordan O; Borchard G
    Drug Deliv; 2016 Oct; 23(8):2747-2755. PubMed ID: 26289209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.